Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph M Herman

Showing results (311-320 of 316) with videos related to

Pageof 32
Sort By:
You have reached the last page of results.This site can display upto 316 results.
Nature Communications|March 19, 2026
The combination of a cancer vaccine, pembrolizumab, and stereotactic body radiation in patients with locally advanced pancreatic cancer: a single-arm, phase II studyValerie Lee, Apoorvaa S Sachidanand, Christina Rodriguez, et al.
Cancer Medicine|June 23, 2017
Long-term survival benefit of upfront chemotherapy in patients with newly diagnosed borderline resectable pancreatic cancerBikram Shrestha, Yifei Sun, Farzana Faisal, et al.
JCO Precision Oncology|April 20, 2023
Complete Remission of Widely Metastatic Human Epidermal Growth Factor Receptor 2-Amplified Pancreatic Adenocarcinoma After Precision Immune and Targeted Therapy With Description of Sequencing and Organoid CorrelatesDaniel A King, Amber R Smith, Gino Pineda, et al.
The Lancet. Oncology|December 1, 2023
Stereotactic body radiotherapy with or without selective dismutase mimetic in pancreatic adenocarcinoma: an adaptive, randomised, double-blind, placebo-controlled, phase 1b/2 trialCullen M Taniguchi, Jessica M Frakes, Todd A Aguilera, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 5, 2020
Vaccine-Induced Intratumoral Lymphoid Aggregates Correlate with Survival Following Treatment with a Neoadjuvant and Adjuvant Vaccine in Patients with Resectable Pancreatic AdenocarcinomaLei Zheng, Ding Ding, Barish H Edil, et al.
Cancer Discovery|December 15, 2015
Whole Genome Sequencing Defines the Genetic Heterogeneity of Familial Pancreatic CancerNicholas J Roberts, Alexis L Norris, Gloria M Petersen, et al.
Pageof 32

Showing results (311-320 of 316) with videos related to

Sort By:
Pageof 32
You have reached the last page of results.This site can display upto 316 results.
Nature Communications|March 19, 2026
The combination of a cancer vaccine, pembrolizumab, and stereotactic body radiation in patients with locally advanced pancreatic cancer: a single-arm, phase II studyValerie Lee, Apoorvaa S Sachidanand, Christina Rodriguez, et al.
Cancer Medicine|June 23, 2017
Long-term survival benefit of upfront chemotherapy in patients with newly diagnosed borderline resectable pancreatic cancerBikram Shrestha, Yifei Sun, Farzana Faisal, et al.
JCO Precision Oncology|April 20, 2023
Complete Remission of Widely Metastatic Human Epidermal Growth Factor Receptor 2-Amplified Pancreatic Adenocarcinoma After Precision Immune and Targeted Therapy With Description of Sequencing and Organoid CorrelatesDaniel A King, Amber R Smith, Gino Pineda, et al.
The Lancet. Oncology|December 1, 2023
Stereotactic body radiotherapy with or without selective dismutase mimetic in pancreatic adenocarcinoma: an adaptive, randomised, double-blind, placebo-controlled, phase 1b/2 trialCullen M Taniguchi, Jessica M Frakes, Todd A Aguilera, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 5, 2020
Vaccine-Induced Intratumoral Lymphoid Aggregates Correlate with Survival Following Treatment with a Neoadjuvant and Adjuvant Vaccine in Patients with Resectable Pancreatic AdenocarcinomaLei Zheng, Ding Ding, Barish H Edil, et al.
Cancer Discovery|December 15, 2015
Whole Genome Sequencing Defines the Genetic Heterogeneity of Familial Pancreatic CancerNicholas J Roberts, Alexis L Norris, Gloria M Petersen, et al.
Pageof 32